Back to Search
Start Over
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.
- Source :
-
American journal of hematology [Am J Hematol] 2021 May 01; Vol. 96 (5), pp. E168-E171. Date of Electronic Publication: 2021 Feb 24. - Publication Year :
- 2021
- Subjects :
- Adenine therapeutic use
Aged
Datasets as Topic statistics & numerical data
Female
Follow-Up Studies
Humans
Leukemia, Lymphocytic, Chronic, B-Cell mortality
Male
Middle Aged
Multicenter Studies as Topic
Prognosis
Progression-Free Survival
Proportional Hazards Models
Reproducibility of Results
Retrospective Studies
Risk Assessment
Survival Analysis
Adenine analogs & derivatives
Antineoplastic Agents therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Piperidines therapeutic use
Protein Kinase Inhibitors therapeutic use
Severity of Illness Index
Subjects
Details
- Language :
- English
- ISSN :
- 1096-8652
- Volume :
- 96
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- American journal of hematology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33580969
- Full Text :
- https://doi.org/10.1002/ajh.26127